Cargando…
Risk of harlequin syndrome during bi-femoral peripheral VA-ECMO: should we pay more attention to the watershed or try to change the venous cannulation site?
Autores principales: | Honore, Patrick M., Barreto Gutierrez, Leonel, Kugener, Luc, Redant, Sebastien, Attou, Rachid, Gallerani, Andrea, De Bels, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372641/ https://www.ncbi.nlm.nih.gov/pubmed/32690070 http://dx.doi.org/10.1186/s13054-020-03168-y |
Ejemplares similares
-
Use of multiple laboratory tests including anti-factor Xa to optimally manage anticoagulation during ECMO
por: Honore, Patrick M., et al.
Publicado: (2020) -
TPE seems to be a treatment that may improve outcomes by effectively removing fibrin degradation products and restoring coagulation status: fact or fiction?
por: Honore, Patrick M., et al.
Publicado: (2020) -
High doses of tigecycline are associated with satisfactory plasmatic and pulmonary concentrations for the treatment of severe infections due to fully susceptible bacteria: do we need even higher doses in patients under CRRT?
por: Honore, Patrick M., et al.
Publicado: (2020) -
Infliximab can reduce mortality from 35 to 14% in critically ill patients with COVID-19: perhaps some potential confounders to consider
por: Honore, Patrick M., et al.
Publicado: (2020) -
Mortality in non-elderly septic patients was increased with hypothermia and decreased with fever while mortality in elderly patients was not associated with body temperature: beware of some confounders!
por: Honore, Patrick M., et al.
Publicado: (2020)